StockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

Equities researchers at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Tuesday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

AMPE stock opened at $0.00 on Tuesday. The business has a 50 day moving average of $0.05 and a 200 day moving average of $0.57. The firm has a market cap of $2,497.00, a PE ratio of 0.00 and a beta of 2.21. Ampio Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $7.47.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.